Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nadia Pillai
Observed name:
N Pillai
Institution:
Johnson & Johnson (Switzerland)
Observed institutions:
Centre Hospitalier Universitaire Vaudois,
Johnson & Johnson (Switzerland),
Institute of Social and Preventive Medicine,
Centre universitaire de médecine générale et santé publique, Lausanne,
Actelion (Switzerland),
University of Lausanne
show all 6
ORCID:
0000-0003-2076-9100
Observed ORCID:
0000-0003-2076-9100
OpenAlex ID:
A5032413669
A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease
2017
·
Nadia Pillai
, Mark Dusheiko
, et al.
·
PLoS ONE
·
112
The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years
2019
·
Nadia Pillai
, Mark Dusheiko
, et al.
·
Journal of Crohn s and Colitis
·
61
Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registries
2023
·
Hannes Runheim
, Barbro Kjellström
, et al.
·
Pulmonary Circulation
·
20
PDF
Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn’s Disease using Real-World Data
2019
·
Nadia Pillai
, Judith E Lupatsch
, et al.
·
Journal of Crohn s and Colitis
·
20
PDF
Association of risk assessment at diagnosis with healthcare resource utilization and health‐related quality of life outcomes in pulmonary arterial hypertension
2024
·
Allan Lawrie
, Neil Hamilton
, et al.
·
Pulmonary Circulation
·
7
Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service
2024
·
David G Kiely
, Neil Hamilton
, et al.
·
BMJ Open
·
7
PDF
Societal costs associated to chronic thromboembolic pulmonary hypertension: A study utilizing linked national registries
2023
·
Barbro Kjellström
, Hannes Runheim
, et al.
·
Pulmonary Circulation
·
5
PDF
Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension
2022
·
Allan Lawrie
, Neil Hamilton
, et al.
·
Pulmonary Circulation
·
5
PDF
Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study
2024
·
Rachael Kendrew
, Salma Ajraoui
, et al.
·
BMC Pulmonary Medicine
·
3
PDF
Health care utilization and productivity loss associated with pulmonary arterial hypertension: a Swedish nationwide register study
2022
·
H Runheim
, B Kjellstrom
, et al.
·
European Heart Journal
·
2
Abstract 11768: Association Between Clinical Events and Subsequent Events Among Anticoagulant Treated Patients with Atrial Fibrillation: Real World Data Analyses in US and UK
2026
·
Amiee Kang
, Ellen S O'Brien
, et al.
·
Circulation
Abstract 5578: Adverse Clinical Events in Secondary Stroke Prevention: A Nationwide Cohort Study in Sweden
2026
·
Meghan Thompson
, Jonas Banefelt
, et al.
·
Circulation
P657 Evolution of Crohn’s disease progression and surgery rates over 10 years for patients who initiated biologic treatment early compared with late or no biologic initiation
2020
·
N Pillai
, M Dusheiko
, et al.
·
Journal of Crohn s and Colitis
PDF
An economic évaluation of inflammatory bowel disease using real world data in Switzerland
2019
·
Nadia Pillai
·
IRIS
PDF
Show more works
View as search
Works count:
14
Citation count:
242
H-index:
6
I10-index:
4
Year
Topic
Type